# Regeneron Pharmaceuticals, Inc. (REGN) — Q3-2012 Earnings Results

**Report date:** 2012-10-24 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/REGN/earnings/Q3-2012

## Post-Earnings Brief

### Headline

Regeneron Pharmaceuticals Beats on EPS, Stock Up 6.34%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.89 | N/A | +104.32% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Confident

Management expressed satisfaction with the quarterly results, highlighting their commitment to pipeline advancements. They did not provide specific guidance for future performance.

**Key quotes:**

> We are pleased with our performance this quarter.

> Our focus remains on advancing our pipeline.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Regeneron's strong earnings per share beat expectations significantly, which contributed to a positive stock reaction, rising by 6.34%. The lack of revenue data leaves some uncertainty, but the management's confidence in their pipeline suggests potential for future growth. Investors may view this as a positive sign for the company's ongoing projects and overall health.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/REGN/earnings/Q3-2012_